An all optical method of implementing a wavelength encoded simultaneous binary full adder-full subtractor unit exploiting nonlinear polarization rotation in semiconductor optical amplifier

Full adders and full subtractors are the basic circuit elements of any digital data processor in electronics as well as in the all optical domain. Again the wavelength dependent encoding/decoding techniques have established itself as a very promising and efficient tool having some inherent and unique advantages relative to the other well known intensity or polarization or phase dependent optical data encoding mechanisms. In this communication, the authors therefore propose a new scheme of implementing a wavelength encoded complete binary full adder-full subtractor unit in the all optical domain using the wavelength conversion by the nonlinear polarization rotation in a single semiconductor optical amplifier. The interacting signals are counter propagating in the semiconductor optical amplifier and hence can be set at the same wavelength. To realize the binary logic wavelength dependent encoding/decoding mechanism is exploited in our proposed scheme of full adder-full subtractor unit. Also the optical add/drop multiplexing employing the special filtering property of the semiconductor optical amplifier is utilized for the designing of the all optical system.     

Injectable hydrogels for targeted delivering of therapeutic molecules for tissue engineering and disease treatment

Hydrogels are cross‐linked three‐dimensional polymeric networks that play a vital role in solving the pharmacological and clinical limitations of the existing systems due to their unique physical properties such as affinity for biological fluids, tunable porous nature, high water content, ease of preparation, flexibility, and biocompatibility. Hydrogel also mimics the living natural tissue, which opens several opportunities for its use in biomedical areas. Injectable hydrogel allows temporal control and exceptional spatial arrangements and can offset hitches with established hydrogel‐based drug delivery systems. Here, we review the recent development of injectable hydrogels and their significance in the delivery of therapeutics such as cells, genes, and drug molecules and how these innovatory systems can complement the current delivery systems.     

Light Harvesting and Directional Energy Transfer in Long‐Lived Homo‐ and Heterotrimetallic Complexes of FeII,RuII, and OsII

A new family of trimetallic complexes of the form [(bpy)₂M(phen‐Hbzim‐tpy)M′(tpy‐Hbzim‐phen)M(bpy)₂]⁶⁺ (M=Ru^II, Os; M′=Fe^II, Ru^II, Os; bpy=2,2′‐bipyridine) derived from heteroditopic phenanthroline–terpyridine bridge 2‐{4‐[2,6‐di(pyridin‐2‐yl) pyridine‐4‐yl]phenyl}‐1H‐imidazole[4,5‐f][1,10]phenanthroline (phen‐Hbzim‐tpy) were prepared and fully characterized. Zn²⁺ was used to prepare mixed‐metal trimetallic complexes in situ by coordinating with the free tpy site of the monometallic precursors. The complexes show intense absorptions throughout the UV/Vis region and also exhibit luminescence at room temperature. The redox behavior of the compounds is characterized by several metal‐centered reversible oxidation and ligand‐centered reduction processes. Steady‐state and time‐resolved luminescence data show that the potentially luminescent Ru^II‐ and Os^II‐based triplet metal‐to‐ligand charge‐transfer (³MLCT) excited states in the triads are quantitatively quenched, most likely by intercomponent energy transfer to the lower lying ³MLCT (for Ru and Os) or triplet metal‐centered (³MC) excited states of the Fe^II subunit (nonluminescent). Interestingly, iron did not adversely affect the photophysics of the respective systems. This suggests that the multicomponent molecular‐wire‐like complexes investigated here can behave as efficient light‐harvesting antennas, because all the light absorbed by the various subunits is efficiently channeled to the subunit(s) in which the lowest‐energy excited states are located.     

Micellar Effect on the Reaction of Chromium(VI) Oxidation of L‐Sorbose in the Presence and Absence of Picolinic Acid in Aqueous Acid Media: A Kinetic Study

The kinetics and mechanism of chromic acid oxidation of L‐sorbose in the presence and absence of picolinic acid (PA) have been studied under the conditions, [L‐sorbose]_T » [PA]_T » [Cr(VI)]_T, at different temperatures. In the absence of PA, the monomeric chromic acid undergoes esterification with the substrate followed by the acid catalysed redox decomposition of the Cr(VI)‐substrate ester through glycol splitting to formaldehyde and the lactone of C₅‐aldonic acid and Cr(IV) which subsequently participates in the faster reactions. In the presence of PA, the Cr(VI)‐PA complex produced in a pre‐equilibrium step experiences a nucleophilic attack by the substrate to produce a ternary complex which decomposes through glycol splitting giving rise to the organic products and Cr(IV)‐PA complex. Both the uncatalysed and PA‐catalysed paths show the first‐order dependence on [L‐sorbose]_T and [Cr(VI)]_T. The PA‐catalysed path is first‐order in [PA]_T and it shows a fractional order in [H⁺]. The uncatalysed path shows a second‐order dependence on [H⁺]. In the presence of the surfactants like N‐cetylpyridinium chloride (CPC, a cationic surfactant) and sodium dodecyl sulfate (SDS, an anionic sulfate), the reaction orders remain unchanged. CPC has been found to inhibit both the uncatalysed and PA‐catalysed paths while SDS shows the rate accelerating effect for both the uncatalysed and PA‐catalysed paths. The observed micellar effects have been rationalised by considering the distribution of the reactants between the micellar and aqueous phases in terms of the proposed reaction mechanism.     

2,4‐Dinitroimidazole: Microwave assisted synthesis and use in synthesis of 2,3‐dihydro‐6‐nitroimidazo[2,1‐b]oxazole analogues with antimycobacterial activity

2,4‐Dinitroimidazole (2,4‐DNI), an important starting material for nitroimidazooxazole and nitroimidazooxazine types of antitubercular agents was synthesized by rearrangement of 1,4‐dinitroimidazole (1,4‐DNI) under microwave irradiation. Various new nitroimidazooxazoles analogues were prepared using 2,4‐DNI and were tested preliminarily against Mycobacterium tuberculosis, H₃₇Rv strain. Some were found to be active.     

On the Power Function of the Likelihood Ratio Test for MANOVA

We prove that the power function of the likelihood ratio test for MANOVA attains its minimum when the rank of the location parameter matrix Θ decreases from s to 1. This provides a theoretical justification of a result that is known in the literature based only on numerical studies.     

Studies on kinetics and mechanism of oxidation of D‐sorbitol and D‐mannitol by cerium(IV) in aqueous micellar sulfuric acid media

The kinetics and mechanism of cerium(IV) oxidation of hexitols, i.e. D ‐sorbitol and D ‐mannitol, in aqueous sulfuric acid media have been studied in the presence and absence of surfactants. Under the kinetic conditions, [S]_T ? [Ce(IV)]_T, where [S]_T is the total substrate (D ‐sorbitol or D ‐mannitol) concentration, the overall process shows a first‐order dependence on [Ce(IV)]_T and [S]_T. The process is acid catalyzed and inhibited by [HSO]. From the [HSO] dependence, it has been noted that the both Ce(SO₄)²⁺ and Ce(SO₄)₂ have been found kinetically active. The different rate constants in the presence and absence of surfactants have been estimated with the activation parameters. N‐cetylpyridinium chloride has been found to retard the oxidation process of hexitols, whereas sodium dodecyl sulfate has been found to accelerate the rate process. All these findings including the micellar effects have been interpreted in terms of the proposed reaction mechanism and partitioning behavior of the kinetically active different species of Ce(IV) between the aqueous and pseudomicellar phase. © 2008 Wiley Periodicals, Inc. 40: 445–453, 2008     

Determination of Drospirenone in Human Plasma by LC–Tandem-MS

A bioanalytical method has been developed and validated for determination of drospirenone in human plasma. The analytical method consists in the extraction of plasma sample with dichloromethane, followed by determination of drospirenone by LC–MS–MS using levonorgestrel as internal standard. Separation was achieved on a Peerless cyano column with an isocratic mobile phase consisting of methanol and ammonium formate buffer. Protonated ions formed by a Turboionspray in the positive mode were used to detect analyte and IS. The MS–MS detection was by monitoring the fragmentation for drospirenone and for levonorgestrel on a triple quadrupole mass spectrometer. The assay was calibrated over the range 5–100 ng mL^?1 with a correlation coefficient of 0.9998. Validation data showed intra-batch (n = 6) CV% ≤ 5.58 and RE (%) between ?3.34 and +6.27 and inter-batch (n = 18) CV% < 6.08 and RE (%) between ?1.84 and +6.73. Mean extraction recovery were 83.31–92.58% for three QC samples and 89.32% for IS. Plasma samples were stable for three freeze-thaw cycles, or 24 h ambient storage, or 1 and 3 months storage at ?20 °C. Processed samples (ready for injection) were stable up to 72 h at autosampler (4 °C). This method has been used for analyzing plasma samples from a bioequivalence study with 12 volunteers.     

A cross-metathesis route to the 5-F(2)-isoprostanes

A library of eight 5-F(2)-isoprostanes was prepared through a ring-opening metathesis/cross-metathesis protocol between functionalized bicyclo[3.2.0]heptenes, ethylene, and alpha,beta-unsaturated ketones. This sequence provided racemic enones in a regio- and stereoselective fashion that could be converted to enantiomerically enriched allylic alcohols through a catalyst-controlled asymmetric reduction. Completion of the sidechains, followed by global deprotection, resulted in a stereodivergent route to eight enantiomerically enriched 5-F(2)-isoprostanes. Overall, the synthesis of this library of known and anticipated lipid oxidation metabolites was achieved in 10 steps from commercially available 4-hydroxy-2-cyclopentenone.